Glyphic Biotechnologies

Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform. While DNA can reveal biological insights, proteins provide the actual insights into the functions of our bodies. The company is in the process of developing a pioneering, next-generation protein sequencing platform that will empower researchers to acquire unprecedented insights into both biology and diseases.

Glyphic Biotechnologies headquartered in New York, New York, United States, North America, operates in the Biotechnology, Life Science, Health Care sector. The company focuses on Biotechnology and has secured $1.0B in funding across 132 round(s). With a team of 11-50 employees, Glyphic Biotechnologies is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Glyphic Biotechnologies, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.